First Manhattan
ARGS

First Manhattan’s Argos Therapeutics, Inc. ARGS Stock Holding History

First Manhattan’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-50
Closed -$2K – 1533
2015
Q4 		$2K Hold
50
– – ﹤0.01% 1360
2015
Q3 		$4K Buy
+50
New +$5.92K ﹤0.01% 1299

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

First Manhattan's ARGS Position: Q1 2016 in Review

First Manhattan sold out of Argos Therapeutics, Inc. (ARGS) in Q1 2016, closing a stake of 50 shares — an estimated $2K sold.

First Manhattan first reported a position in ARGS in Q3 2015 and held it in 2 quarters. The position peaked at $4K in Q3 2015. 21 funds tracked by Wall St. Rank hold ARGS as of Q1 2016.

  • First Manhattan reported no remaining Argos Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • First Manhattan sold 50 Argos Therapeutics, Inc. shares in Q1 2016, an estimated $2K.
  • First Manhattan first reported a position in Argos Therapeutics, Inc. in Q3 2015 and held it in 2 quarters.
  • First Manhattan's Argos Therapeutics, Inc. position peaked at $4K in Q3 2015.
  • 21 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q1 2016.

Based on First Manhattan's 13F filing for Q1 2016, filed 22 Apr 2016.